These success, together with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the notion of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-linked disorders. By ticking this box and publishing https://williamq479tqk8.wikifrontier.com/user